Formycon AG（FYBGF）價格

Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 245 full-time employees. The company went IPO on 2010-12-20. The firm is engaged in providing biosimilar drugs and formulations. The firm focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.